Genus plc (GNS.L) announced, on 31 March 2017, an injunction was awarded in its favour in connection with the litigation against Inguran, operating as Sexing Technologies. The injunction will remain in force for five years. As a result, contractual restrictions blocking the way for commercial launch of Genus Sexed Semen have been removed by the Court. Genus plans commercial launch of Genus Sexed Semen in the US and other key markets globally during the course of 2017.
Genus plc said the Court confirmed that: Sexing Technologies is prevented from enforcing certain research, marketing and non-compete restrictions under the 2012 Semen Sorting Agreement between ST and ABS Global, Inc., an affiliate of Genus; and other bull studs in the US are permitted to terminate their ST sexed semen processing agreements on 12 months' notice, without damage or penalty.
Genus said the Group will consider its options for appeal in relation to other post-verdict motion decisions from the Court, including the Court's decision to support the validity of certain ST patents.
For comments and feedback: editorial@rttnews.com